Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Janney Montgomery Scott Upgrades Byline Bancorp to Buy

Janney Montgomery Scott analyst Brian Martin upgrades Byline Bancorp (NYSE:BY) from Neutral to Buy.

byBenzinga Newsdesk

May 17, 2022

1 minute read

Janney Montgomery Scott analyst Brian Martin upgrades Byline Bancorp (NYSE:BY) from Neutral to Buy.

News

Cybin Reports Its Wholly-Controlled Subsidiary Adelia Therapeutics Achieved Milestone

By Benzinga Newsdesk

Today, 10:33 AM

Cybin Inc. (NEO:CYBN) (NYSE:CYBN) (“Cybin” or the “Company”), a biotechnology company focused on psychedelic pharmaceutical therapies, is pleased to announce that Adelia Therapeutics Inc.

CYBN

Fed’s Brainard Says It Does Take Time For Cumulative Tightening To Be Fully Visible In The Economy

By Benzinga Newsdesk

Today, 10:33 AM

Live TV - Bloomberg

SPY

Credit Suisse Maintains Neutral on Hess Midstream, Raises Price Target to $27

By Benzinga Newsdesk

Today, 10:33 AM

Credit Suisse analyst Douglas Irwin maintains Hess Midstream (NYSE:HESM) with a Neutral and raises the price target from $25 to $27.

HESM

Vuzix Formalizes Reseller Agreement With VR Expert; Terms Not Disclosed

By Benzinga Newsdesk

Today, 10:33 AM

Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that it has

VUZI

Janney Montgomery Scott Upgrades Byline Bancorp to Buy

Related Posts

Cybin Reports Its Wholly-Controlled Subsidiary Adelia Therapeutics Achieved Milestone

Fed’s Brainard Says It Does Take Time For Cumulative Tightening To Be Fully Visible In The Economy

Credit Suisse Maintains Neutral on Hess Midstream, Raises Price Target to $27

Vuzix Formalizes Reseller Agreement With VR Expert; Terms Not Disclosed